Why Many Patients Prefer Not to Be Called 'Brave'

Bravery implies a choice. You chose to run into the burning building; you could have stayed outside. Cancer treatment is rarely like that. You go to the infusion chair because the alternative is untreated cancer, and there is no version of the week where declining was a live option. So when someone calls you brave for keeping an appointment, the compliment quietly recategorises an ordinary Tuesday as a moral achievement you did not earn.

For a lot of people that is the whole irritation. It is not offensive. It is just inaccurate, and hearing an inaccurate thing forty times gets tiring.

Watch when it arrives. "You're so brave" tends to surface at the exact moment the other person runs out of things to say — after you mention a scan date, or a drug name, or the fact that you are tired. It closes the conversation on a high note and lets everyone step back from the edge.

That is not malice. Most people have no script for this and reach for the nearest warm phrase. But it does mean the word is often doing work for them rather than for you, and that is why it can land as a dismissal.

The bigger cost is what comes attached. Being cast as the brave one carries an unwritten job description: stay upbeat, keep the symptoms light, and send visitors home reassured. Once people have decided you are inspirational, contradicting them takes energy, so a lot of people simply stop mentioning the bad weeks.

That silence is measurable. Researchers call it social constraints — the sense that the people around you do not want to hear it. A meta-analysis of 30 studies in cancer patients found social constraints on disclosure moderately correlated with both general and cancer-specific distress, around r = 0.37 for each. Editing yourself to keep other people comfortable has a price, and it is not a small one.

The expectation that patients perform optimism is old enough to have a name. Jimmie Holland, who founded the psycho-oncology service at Memorial Sloan Kettering, titled a chapter of her 2000 book The Human Side of Cancer "The Tyranny of Positive Thinking" — her argument being that patients were being handed responsibility for outcomes they could not influence.

The evidence is on her side. The National Cancer Institute states plainly that "there is no convincing scientific evidence that links a person's 'attitude' to their risk of developing or dying from cancer." Whatever your outlook is on a given Thursday, it is not holding back your treatment, and nobody gets to imply otherwise.

Long explanations invite debate. Short ones do not.

• "I'm not brave, I just don't have another option."
• "Honestly it's mostly admin and waiting rooms."
• "I'd rather you asked how the week went."
• "Thanks — though I'd take 'that sounds exhausting' over 'brave' any day."

If a particular person keeps at it, naming what you want instead is more effective than naming what you dislike: "It helps more when you just ask what's happening." People generally want a usable instruction.

Clinicians say it too, often at the end of an appointment. The risk there is practical: if you are being read as coping well, your symptoms and distress can get recorded as milder than they are. It is reasonable to say, flatly, "I'm managing, but I'm not fine — can we go through the fatigue properly?" Ask what is written in the notes. Ask for a referral to psycho-oncology or an oncology social worker if you want somewhere to talk without performing anything.

• NCI: Common Cancer Myths and Misconceptions (attitude and outcome)
• Adams, Winger & Mosher, A meta-analysis of the relationship between social constraints and distress in cancer patients (J Behav Med, 2015)
• Zarei et al., Social relationship challenges perceived by cancer patients and survivors (BMC Psychology, 2025)